Ondansetron Tablet, Orally Disintegrating
Product Images NDC 68071-2763

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 68071-2763). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 2763 3)

Packaging label for Ondansetron ODT 8 mg orally disintegrating tablets by NuCare Pharmaceuticals, Inc. The package contains 30 tablets. It includes storage instructions to keep at controlled temperature 68-77°F and warnings to keep out of reach of children. Manufactured by Aurobindo Pharma Limited, Hyderabad, India.*

FDA Label Image

Chemical Structure (Ondansetronod Str)

Chemical structure diagram of the active ingredient Ondansetron, showing its molecular configuration with rings and functional groups as part of its chemical formula.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.